Form 8-K - Current report
SEC Accession No. 0001193125-26-378360
Filing Date
2026-09-01
Accepted
2026-09-01 16:01:24
Documents
11
Period of Report
2026-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d262303d8k.htm   iXBRL 8-K 22891
  Complete submission text file 0001193125-26-378360.txt   137686

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA almr-20260828.xsd EX-101.SCH 3203
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE almr-20260828_lab.xml EX-101.LAB 17975
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE almr-20260828_pre.xml EX-101.PRE 11273
14 EXTRACTED XBRL INSTANCE DOCUMENT d262303d8k_htm.xml XML 3634
Mailing Address 47071 BAYSIDE PARKWAY FREMONT CA 94538
Business Address 47071 BAYSIDE PARKWAY FREMONT CA 94538 510-626-9888
Alamar Biosciences, Inc. (Filer) CIK: 0002104204 (see all company filings)

EIN.: 364899036 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-43235 | Film No.: 261350610
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)